BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 29576309)

  • 1. Preventive effect of oral hangeshashinto (TJ-14) on the development of reflux-induced esophageal cancer.
    Miyashita T; Kono T; Matsui D; Yamazaki Y; Sadatomi D; Fujitsuka N; Nakanuma S; Okamoto K; Makino I; Kinoshita J; Nakamura K; Oyama K; Tajima H; Takamura H; Ninomiya I; Fushida S; Mukaisho K; Harmon JW; Ohta T
    Surgery; 2018 Mar; ():. PubMed ID: 29576309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of inflammation-metaplasia-adenocarcinoma sequence and inflammatory microenvironment in esophageal carcinogenesis using surgical rat models.
    Miyashita T; Tajima H; Shah FA; Oshima M; Makino I; Nakagawara H; Kitagawa H; Fujimura T; Harmon JW; Ohta T
    Ann Surg Oncol; 2014 Jun; 21(6):2012-9. PubMed ID: 24526548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histopathologic evaluation of an animal model for Barrett's esophagus and adenocarcinoma of the distal esophagus.
    Buskens CJ; Hulscher JB; van Gulik TM; Ten Kate FJ; van Lanschot JJ
    J Surg Res; 2006 Oct; 135(2):337-44. PubMed ID: 16926029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From Reflux Esophagitis to Esophageal Adenocarcinoma.
    Souza RF
    Dig Dis; 2016; 34(5):483-90. PubMed ID: 27331918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors influencing the development of Barrett's epithelium in the esophageal remnant postesophagectomy.
    O'Riordan JM; Tucker ON; Byrne PJ; McDonald GS; Ravi N; Keeling PW; Reynolds JV
    Am J Gastroenterol; 2004 Feb; 99(2):205-11. PubMed ID: 15046206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rabeprazole impedes the development of reflux-induced esophageal cancer in a surgical rat model.
    Miyashita T; Shah FA; Marti GP; Wang J; Bonde P; Gibson MK; Ohta T; Montgomery EA; Duncan M; Harmon JW
    Dig Dis Sci; 2011 May; 56(5):1309-14. PubMed ID: 21053077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of gastroduodenal juice and dietary fat on the development of Barrett's esophagus and esophageal neoplasia: an experimental rat model.
    Clark GW; Smyrk TC; Mirvish SS; Anselmino M; Yamashita Y; Hinder RA; DeMeester TR; Birt DF
    Ann Surg Oncol; 1994 May; 1(3):252-61. PubMed ID: 7842295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indomethacin but not a selective cyclooxygenase-2 inhibitor inhibits esophageal adenocarcinogenesis in rats.
    Esquivias P; Morandeira A; Escartín A; Cebrián C; Santander S; Esteva F; García-González MA; Ortego J; Lanas A; Piazuelo E
    World J Gastroenterol; 2012 Sep; 18(35):4866-74. PubMed ID: 23002358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Barrett's metaplasia develops from cellular reprograming of esophageal squamous epithelium due to gastroesophageal reflux.
    Minacapelli CD; Bajpai M; Geng X; Cheng CL; Chouthai AA; Souza R; Spechler SJ; Das KM
    Am J Physiol Gastrointest Liver Physiol; 2017 Jun; 312(6):G615-G622. PubMed ID: 28336546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant epithelial-mesenchymal Hedgehog signaling characterizes Barrett's metaplasia.
    Wang DH; Clemons NJ; Miyashita T; Dupuy AJ; Zhang W; Szczepny A; Corcoran-Schwartz IM; Wilburn DL; Montgomery EA; Wang JS; Jenkins NA; Copeland NA; Harmon JW; Phillips WA; Watkins DN
    Gastroenterology; 2010 May; 138(5):1810-22. PubMed ID: 20138038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Double-blind, placebo-controlled, randomized phase II study of TJ-14 (hangeshashinto) for gastric cancer chemotherapy-induced oral mucositis.
    Aoyama T; Nishikawa K; Takiguchi N; Tanabe K; Imano M; Fukushima R; Sakamoto J; Oba MS; Morita S; Kono T; Tsuburaya A
    Cancer Chemother Pharmacol; 2014 May; 73(5):1047-54. PubMed ID: 24652604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rat Reflux Model of Esophageal Cancer and Its Implication in Human Disease.
    Greene CL; Worrell SG; DeMeester TR
    Ann Surg; 2015 Dec; 262(6):910-24. PubMed ID: 25822684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Duodenal-content reflux esophagitis induces the development of glandular metaplasia and adenosquamous carcinoma in rats.
    Pera M; Brito MJ; Poulsom R; Riera E; Grande L; Hanby A; Wright NA
    Carcinogenesis; 2000 Aug; 21(8):1587-91. PubMed ID: 10910963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in ERK activation in squamous mucosa in patients who have gastroesophageal reflux disease with and without Barrett's esophagus.
    Souza RF; Shewmake KL; Shen Y; Ramirez RD; Bullock JS; Hladik CL; Lee EL; Terada LS; Spechler SJ
    Am J Gastroenterol; 2005 Mar; 100(3):551-9. PubMed ID: 15743351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Host factors influence Barrett's carcinogenesis: findings from a mouse gastroduodenal reflux model.
    Kanai S; Mukaisho KI; Yoshida S; Taniura N; Sugihara H
    Esophagus; 2019 Jul; 16(3):264-271. PubMed ID: 30790117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A human Barrett's esophagus organoid system reveals epithelial-mesenchymal plasticity induced by acid and bile salts.
    Zhang Q; Bansal A; Dunbar KB; Chang Y; Zhang J; Balaji U; Gu J; Zhang X; Podgaetz E; Pan Z; Spechler SJ; Souza RF
    Am J Physiol Gastrointest Liver Physiol; 2022 Jun; 322(6):G598-G614. PubMed ID: 35380457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Topical Hangeshashinto (TJ-14) on Chemotherapy-Induced Oral Mucositis.
    Ozawa N; Onda T; Hayashi K; Honda H; Shibahara T
    Cancer Manag Res; 2020; 12():1069-1078. PubMed ID: 32104087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of oxidant production in esophageal squamous cell and Barrett's cell lines.
    Feagins LA; Zhang HY; Zhang X; Hormi-Carver K; Thomas T; Terada LS; Spechler SJ; Souza RF
    Am J Physiol Gastrointest Liver Physiol; 2008 Feb; 294(2):G411-7. PubMed ID: 18063706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccine impedes the development of reflux-induced esophageal cancer in a surgical rat model: efficacy of the vaccine in a Pre-Barrett's esophagus setting.
    Miyashita T; Shah FA; Marti G; Wang J; Armstrong T; Bonde P; Gibson MK; Yoshimura K; Montgomery EA; Duncan MD; Jaffee EM; Harmon JW
    J Gastrointest Surg; 2008 Jan; 12(1):2-7; discussion 7-9. PubMed ID: 17957441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acid and bile salt-induced CDX2 expression differs in esophageal squamous cells from patients with and without Barrett's esophagus.
    Huo X; Zhang HY; Zhang XI; Lynch JP; Strauch ED; Wang JY; Melton SD; Genta RM; Wang DH; Spechler SJ; Souza RF
    Gastroenterology; 2010 Jul; 139(1):194-203.e1. PubMed ID: 20303354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.